Suppr超能文献

研究播散性休眠癌细胞免疫调节的技术进展

Technical Advancements for Studying Immune Regulation of Disseminated Dormant Cancer Cells.

作者信息

Ombrato Luigi, Montagner Marco

机构信息

Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.

Department of Molecular Medicine, School of Medicine and Surgery, University of Padua, Padua, Italy.

出版信息

Front Oncol. 2020 Nov 4;10:594514. doi: 10.3389/fonc.2020.594514. eCollection 2020.

Abstract

Metastases are a major cause of cancer-related death and despite the fact that they have been focus of intense research over the last two decades, effective therapies for patients with distant secondary lesions are still very limited. In addition, in some tumor types metastases can grow years after the patients have been declared clinically cured, indicating that disseminated cancer cells (DCCs) persist undetected for years, even decades in a quiescent state. Clinical and experimental data highlight the importance of the immune system in shaping the fitness and behaviour of DCCs. Here, we review mechanisms of survival, quiescence and outgrowth of DCCs with a special focus on immune-regulation and we highlight the latest cutting-edge techniques for modelling the biology of DCCs and for studying the metastatic niche . We believe that a wide dissemination of those techniques will boost scientific findings towards new therapies to defeat metastatic relapses in cancer patients.

摘要

转移是癌症相关死亡的主要原因,尽管在过去二十年中它们一直是深入研究的焦点,但针对远处继发性病变患者的有效治疗方法仍然非常有限。此外,在某些肿瘤类型中,转移可在患者被宣布临床治愈数年之后出现,这表明播散性癌细胞(DCC)多年来一直未被检测到,甚至在静止状态下持续数十年。临床和实验数据凸显了免疫系统在塑造DCC的适应性和行为方面的重要性。在此,我们回顾DCC的存活、静止和生长机制,特别关注免疫调节,并强调用于模拟DCC生物学特性和研究转移微环境的最新前沿技术。我们相信,广泛传播这些技术将推动科学研究成果,以开发新疗法来战胜癌症患者的转移复发。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0860/7672194/bcd54d5ae67d/fonc-10-594514-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验